Relatedly, while loss of function mutations in negative regulators of RAS signaling (e.g., RASA1/p120 RAS-GAP) are associated with CM-AVM1 (capillary malformation-AVM) in humans, bAVMs are not a prominent feature in these patients [169, 170]. This evidence concerns the gene RASA1 and cutaneous mastocytosis.